Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
757 Westwood Plz
Los Angeles, CA 90095Phone+1 310-206-6766
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2005 - 2008
- Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2000 - 2005
- David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
- CA State Medical License 2003 - 2025
- MA State Medical License 2003 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV Start of enrollment: 2017 May 31
Publications & Presentations
PubMed
- 42 citationsBarriers and facilitators to the uptake of Test and Treat in Mozambique: A qualitative study on patient and provider perceptions.Pedroso Nhassengo, Fabian Cataldo, Amílcar Magaço, Risa M Hoffman, Lucas Nerua
Plos One. 2018-12-26 - 3 citationsThe Outcomes of Transition from Pediatrics to Adult Care among Adolescents and Young Adults with HIV at a Tertiary Care Center in Bangkok.Supattra Rungmaitree, Nuchanat Thamniamdee, Saranya Sachdev, Wanatpreeya Phongsamart, Keswadee Lapphra
Journal of the International Association of Providers of AIDS Care. 2022-12-07 - 8 citationsTranslating Predictions of Zoonotic Viruses for Policymakers.Seth D. Judson, Matthew LeBreton, Trevon Fuller, Risa M Hoffman, Kevin Y. Njabo
Ecohealth. 2018-03-01
Press Mentions
- Three Steps to Speedier HIV Med Approvals for Pregnant PeopleJune 10th, 2021
- Benefits Outweigh Risks of Dolutegravir for Women of Childbearing Age Living with HIV, Study ShowsApril 3rd, 2019
- Avoiding Dolutegravir in Young Women with HIV: Time for a Rethink?April 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: